Posted On: 09/02/2014 8:55:30 PM
Post# of 30066
Re: biotechexpert #5371
Gerald clearly provided LymPro revenue guidance as follows:
$150 million opportunity as an RUO - research use only device
4Q14 we are in LDT - laboratory development stages
post CLIA, formal commercialization = $500-Mil. - $1-Bil. market
$150 million opportunity as an RUO - research use only device
4Q14 we are in LDT - laboratory development stages
post CLIA, formal commercialization = $500-Mil. - $1-Bil. market
(0)
(0)
